2 Fintech Winners From a Coronavirus Vaccine and 2 That Are Under Pressure

When Pfizer (NYSE: PFE) announced positive preliminary data from its COVID-19 vaccine trials, the financial sector was one of the biggest beneficiaries. But not all fintech stocks reacted in the same way.

In this Nov. 9 Fool Live video clip, Fool.com contributor Matt Frankel, CFP, and Industry Focus host Jason Moser discuss why Visa (NYSE: V) and Mastercard (NYSE: MA) soared on the positive vaccine news while Square (NYSE: SQ) and PayPal (NASDAQ: PYPL) underperformed. 

Continue reading

Source Fool.com